1 week Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength? Zacks
AngioDynamics (ANGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
X